Axa
ZLAB icon

Axa’s Zai Lab ZLAB Stock Holding History

Axa’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-65,814
Closed -$2.3M – 1053
2025
Q2 		$2.3M Hold
65,814
– – 0.01% 746
2025
Q1 		$2.38M Hold
65,814
– – 0.01% 703
2024
Q4 		$1.72M Hold
65,814
– – 0.01% 783
2024
Q3 		$1.59M Hold
65,814
– – ﹤0.01% 795
2024
Q2 		$1.14M Sell
65,814
-9,126
-12% -$160K ﹤0.01% 857
2024
Q1 		$1.2M Sell
74,940
-80,835
-52% -$1.7M ﹤0.01% 825
2023
Q4 		$4.26M Sell
155,775
-12,939
-8% -$342K 0.01% 587
2023
Q3 		$4.1M Sell
168,714
-152,330
-47% -$4.06M 0.01% 570
2023
Q2 		$8.9M Buy
321,044
+14,352
+5% +$469K 0.03% 437
2023
Q1 		$10.2M Buy
306,692
+10,386
+4% +$399K 0.04% 407
2022
Q4 		$9.1M Buy
296,306
+40,613
+16% +$1.28M 0.03% 460
2022
Q3 		$8.74M Buy
255,693
+60,692
+31% +$2.6M 0.03% 460
2022
Q2 		$6.76M Buy
+195,001
New +$6.88M 0.03% 510
2022
Q1 		– Sell
-338,991
Closed -$21.3M – 1251
2021
Q4 		$21.3M Buy
338,991
+96,151
+40% +$8.15M 0.05% 344
2021
Q3 		$25.6M Buy
242,840
+6,254
+3% +$898K 0.07% 296
2021
Q2 		$41.9M Buy
236,586
+89,127
+60% +$14.3M 0.12% 202
2021
Q1 		$19.7M Buy
+147,459
New +$22.8M 0.06% 345
2020
Q4 		– Sell
-133,054
Closed -$11.1M – 1364
2020
Q3 		$11.1M Sell
133,054
-15,938
-11% -$1.28M 0.04% 421
2020
Q2 		$12.2M Sell
148,992
-6,220
-4% -$421K 0.05% 384
2020
Q1 		$7.99M Sell
155,212
-78,716
-34% -$4.1M 0.04% 405
2019
Q4 		$9.73M Buy
233,928
+57,691
+33% +$2.13M 0.04% 458
2019
Q3 		$5.7M Buy
176,237
+31,068
+21% +$1.07M 0.02% 606
2019
Q2 		$5.06M Buy
+145,169
New +$4.28M 0.02% 652

Other funds holding ZLAB

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Axa's ZLAB Position: Q3 2025 in Review

Axa sold out of Zai Lab (ZLAB) in Q3 2025, closing a stake of 65,814 shares — an estimated $2.3M sold.

Axa first reported a position in ZLAB in Q2 2019 and held it in 23 quarters. The position peaked at $41.9M in Q2 2021. 138 funds tracked by Wall St. Rank hold ZLAB as of Q3 2025.

  • Axa reported no remaining Zai Lab position as of Q3 2025 after selling out during the quarter.
  • Axa sold 65,814 Zai Lab shares in Q3 2025, an estimated $2.3M.
  • Axa first reported a position in Zai Lab in Q2 2019 and held it in 23 quarters.
  • Axa's Zai Lab position peaked at $41.9M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Zai Lab as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.